[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342730-105":59,"doc-detail-342730-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","sf3b3-regulated-mtor-alternative-splicing-promotes-colorectal-cancer-progression-and-metastasis","SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis","","Aberrant alternative splicing drives colorectal cancer (CRC) development, but the specific role of SF3B3 remains unclear. SF3B3, a splicing factor component of U2 snRNP crucial for early spliceosome assembly, is shown to be upregulated in CRC and linked to poor patient outcomes. SF3B3 inhibition suppresses CRC proliferation and metastasis via mitochondria injury, increased ROS, apoptosis, and increased mTOR exon-skipped splicing, reducing lipogenesis through mTOR-SREBF1-FASN signaling. Combined SF3B3 knockdown and mTOR inhibitors act synergistically in organoids and xenografts.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sf3b3-regulated-mtor-alternative-splicing-promotes-colorectal-cancer-progression-and-metastasis/342730/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sf3b3-regulated-mtor-alternative-splicing-promotes-colorectal-cancer-progression-and-metastasis/342730.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address about colorectal cancer?","Question",{"text":112,"@type":113},"The study focuses on how aberrant alternative splicing contributes to colorectal cancer progression and metastasis, and specifically seeks to clarify SF3B3’s role in CRC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was SF3B3 investigated in CRC?",{"text":117,"@type":113},"SF3B3 expression was analyzed using public CRC datasets plus immunohistochemistry, qRT-PCR, and western blot. Functional studies used RNA-seq, RNA immunoprecipitation, lipidomics, and multiple CRC in vivo models including xenografts and patient-derived systems.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links SF3B3 to mTOR and tumor effects?",{"text":121,"@type":113},"SF3B3 silencing increases mTOR exon-skipped splicing, which suppresses lipogenesis via the mTOR-SREBF1-FASN signaling axis, alongside mitochondrial injury, increased ROS, and apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342730,1790768883,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Xu etal. J Exp Clin Cancer Res (2024) 43:126 [https://doi.org/10.1186/s13046-024-03053-4](https://doi.org/10.1186/s13046-024-03053-4)  \nJournal of Experimental & Clinical Cancer Research  \n RESEARCH Open Access  \nSF3B3-regulated mTOR alternative splicing   promotes colorectal cancer progression and metastasis  \nTong Xu1, Xichuan Li2, Wennan Zhao1, Xue Wang3, Leixin Jin4, Zhiqiang Feng4, Huixiang Li1, Mingzhe Zhang1, Yiqing Tian1, Ge Hu1, Yuan Yue2, Xintong Dai5, Changliang Shan5, Weihua Zhang6, Chunze Zhang4* and Youcai Zhang1*  \nAbstract  \nBackground Aberrant alternative splicing (AS) is a pervasive event during colorectal cancer (CRC) development. SF3B3 is a splicing factor component of U2 small nuclear ribonucleoproteins which are crucial for early stages of spliceosome assembly. The role of SF3B3 in CRC remains unknown.  \nMethods SF3B3 expression in human CRCs was analyzed using publicly available CRC datasets, immunohistochemistry, qRT-PCR, and western blot. RNA-seq, RNA immunoprecipitation, and lipidomics were performed in SF3B3 knockdown or overexpressing CRC cell lines. CRC cell xenografts, patient-derived xenografts, patient-derived organoids, and orthotopic metastasis mouse models were utilized to determine the in vivo role of SF3B3 in CRC progression and metastasis.  \nResults SF3B3 was upregulated in CRC samples and associated with poor survival. Inhibition of SF3B3 by RNA silencing suppressed the proliferation and metastasis of CRC cells in vitro and in vivo, characterized by mitochondria injury, increased reactive oxygen species (ROS), and apoptosis. Mechanistically, silencing of SF3B3 increased mTOR exon-skipped splicing, leading to the suppression of lipogenesis via mTOR-SREBF1-FASN signaling. The combination ofSF3B3 shRNAs and mTOR inhibitors showed synergistic antitumor activity in patient-derived CRC organoidsand xenografts. Importantly, we identified SF3B3 as a critical regulator of mTOR splicing and autophagy in multiple cancers.  \nConclusions Our findings revealed that SF3B3 promoted CRC progression and metastasis by regulating mTOR alternative splicing and SREBF1-FASN-mediated lipogenesis, providing strong evidence to support SF3B3 as a druggable target for CRC therapy.  \nKeywords SF3B3, mTOR, Colorectal cancer, Metastasis, Alternative splicing  \n*Correspondence:  \nChunze Zhang [chunze.zhang@nankai.edu.cn](chunze.zhang@nankai.edu.cn)[ ](chunze.zhang@nankai.edu.cn)Youcai Zhang [youcai.zhang@tju.edu.cn](youcai.zhang@tju.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativecom](http://creativecom)[mons.org/publicdomain/zero/1.0/](mons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nXu etal. J Exp Clin Cancer Res (2024) 43:126  \nBackground  \nColorectal cancer (CRC) ","cbCaioCr5epQXCnU","https://ap.wps.com/l/cbCaioCr5epQXCnU","pdf",6125053,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Article Background","[{\"question\":\"What problem does the study address about colorectal cancer?\",\"answer\":\"The study focuses on how aberrant alternative splicing contributes to colorectal cancer progression and metastasis, and specifically seeks to clarify SF3B3’s role in CRC.\"},{\"question\":\"How was SF3B3 investigated in CRC?\",\"answer\":\"SF3B3 expression was analyzed using public CRC datasets plus immunohistochemistry, qRT-PCR, and western blot. Functional studies used RNA-seq, RNA immunoprecipitation, lipidomics, and multiple CRC in vivo models including xenografts and patient-derived systems.\"},{\"question\":\"What mechanism links SF3B3 to mTOR and tumor effects?\",\"answer\":\"SF3B3 silencing increases mTOR exon-skipped splicing, which suppresses lipogenesis via the mTOR-SREBF1-FASN signaling axis, alongside mitochondrial injury, increased ROS, and apoptosis.\"}]","SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis | PDF",1790047929,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e383fc00c3f24387f13cd2780897428.webp",983,1305,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67765c7149db1e1131006ef2baa4beb4.webp",982,1304,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f046eae9bc6610c28355e6412341353.webp",981,1303,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/24fb5f5212fdb2881568f6281a2d53d3.webp",980,1301]